This is generally a self-limiting disorder.[12]Kapur N, Kamel IR, Herlich A. Oral and craniofacial pain: diagnosis, pathophysiology and treatment. Int Anesthesiol Clin. 2003;41:115-50.
http://www.ncbi.nlm.nih.gov/pubmed/12872029?tool=bestpractice.com
The pain and clicking of TMDs rarely become more serious.[18]LeResche L. Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors. Crit Rev Oral Biol Med. 1997;8:291-305.
http://journals.sagepub.com/doi/pdf/10.1177/10454411970080030401
http://www.ncbi.nlm.nih.gov/pubmed/9260045?tool=bestpractice.com
Joint noises in the absence of pain do not require treatment. Most symptoms of TMDs improve without medical treatment or within 3-6 months of non-surgical treatment.[45]The Royal College of Surgeons of England. Commissioning guide 2014: Temporomandibular joint disorders. 2014 [internet publication].
https://www.rcseng.ac.uk/library-and-publications/rcs-publications/az
Patients should be referred to a specialist if:
Patient has a medical history of inflammatory joint disease
Symptoms do not improve after 6 weeks
There is progressive difficulty in opening the mouth
There is an inability to eat a normal diet
Acute severe restriction of opening <26 mm in a young adult
There is recurrent dislocation of the temporomandibular joint - two or more episodes requiring manual reduction.[45]The Royal College of Surgeons of England. Commissioning guide 2014: Temporomandibular joint disorders. 2014 [internet publication].
https://www.rcseng.ac.uk/library-and-publications/rcs-publications/az
Anchored disc phenomenon warrants urgent referral, as leaving the situation without intervention can lead to permanent restriction of mouth opening.
Non-pharmacological therapy
Patient education and self-management
Educating and reassuring the patients that the condition is benign and non-progressive can be helpful.[49]Shah A, Naqvi A. Temporomandibular disorder: a guide for general dental practitioners. Prim Dent J. 2022 Sep;11(3):118-25.
http://www.ncbi.nlm.nih.gov/pubmed/36073047?tool=bestpractice.com
Patient information and anatomical diagrams explaining the condition and therapeutic approaches can be provided.[2]Durham J, Newton-John TR, Zakrzewska JM. Temporomandibular disorders. BMJ. 2015 Mar 12;350:h1154.
http://www.ncbi.nlm.nih.gov/pubmed/25767130?tool=bestpractice.com
[49]Shah A, Naqvi A. Temporomandibular disorder: a guide for general dental practitioners. Prim Dent J. 2022 Sep;11(3):118-25.
http://www.ncbi.nlm.nih.gov/pubmed/36073047?tool=bestpractice.com
BMJ Best Practice: patient information - temporomandibular disorders
Opens in new window
Upon diagnosis, patients should be advised to begin joint rest immediately to allow the muscles of mastication to relax and reduce mandibular condyle movement. Instructions include avoiding chewing gum, biting nails, or talking excessively. Patients should follow a soft diet and should be counselled to reduce stress.[49]Shah A, Naqvi A. Temporomandibular disorder: a guide for general dental practitioners. Prim Dent J. 2022 Sep;11(3):118-25.
http://www.ncbi.nlm.nih.gov/pubmed/36073047?tool=bestpractice.com
Stress may lead to para-functional habits like bruxism or clenching. Relaxation techniques such as diaphragmatic breathing may be beneficial.[2]Durham J, Newton-John TR, Zakrzewska JM. Temporomandibular disorders. BMJ. 2015 Mar 12;350:h1154.
http://www.ncbi.nlm.nih.gov/pubmed/25767130?tool=bestpractice.com
Advise patients to massage the areas of spasm for 1 minute, four times per day.
Cognitive behavioural therapy (CBT)
CBT aims to teach patients how to cope up with their pain. CBT with or without biofeedback or relaxation therapy is the ideal psychological treatment for managing chronic pain.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227.
https://www.bmj.com/content/383/bmj-2023-076227.long
http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com
[50]Molin C. From bite to mind: TMD - a personal and literature review. Int J Prosthodont. 1999;12:279-88.
http://www.ncbi.nlm.nih.gov/pubmed/10635197?tool=bestpractice.com
[51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226.
https://www.bmj.com/content/383/bmj-2023-076226.long
http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
In one randomised controlled trial, CBT reduced pain and disability to the same extent as occlusal splint therapy, but it was more effective at improving patient pain-coping skills.[52]Shedden Mora MC, Weber D, Neff A, et al. Biofeedback-based cognitive-behavioral treatment compared with occlusal splint for temporomandibular disorder: a randomized controlled trial. Clin J Pain. 2013;29:1057-65.
http://www.ncbi.nlm.nih.gov/pubmed/23446073?tool=bestpractice.com
One systematic review found that CBT was slightly better than alternative treatments in reducing pain intensity or psychological distress. However, the evidence was of low or very low certainty.[53]Penlington C, Bowes C, Taylor G, et al. Psychological therapies for temporomandibular disorders (TMDs). Cochrane Database Syst Rev. 2022 Aug 11;(8):CD013515.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013515.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/35951347?tool=bestpractice.com
If CBT is unavailable, offer an alternative treatment.
Physiotherapy
Physiotherapy may be useful if provided by a specialist TMD physiotherapist. One systematic review and meta-analysis found that therapy and exercise interventions reduced pain and improved maximum mouth opening in patients with TMDs.[54]Arribas-Pascual M, Hernández-Hernández S, Jiménez-Arranz C, et al. Effects of physiotherapy on pain and mouth opening in temporomandibular disorders: an umbrella and mapping systematic review with meta-meta-analysis. J Clin Med. 2023 Jan 18;12(3):788.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917698
http://www.ncbi.nlm.nih.gov/pubmed/36769437?tool=bestpractice.com
In patients with chronic pain associated with trigger points, manual trigger point therapy can be employed wherein a physiotherapist applies targeted pressure with hands to promote circulation in affected areas. This helps release muscle knots and provides relief from pain.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227.
https://www.bmj.com/content/383/bmj-2023-076227.long
http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com
[51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226.
https://www.bmj.com/content/383/bmj-2023-076226.long
http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
Intra-oral devices, splints, night guards, and bite guards
If symptoms do not improve after 2 weeks’ joint rest, patients may be referred to their dental practitioner to construct an oral splint. These should cover the whole of the occlusal surface of one arch. Some studies indicate that hard stabilisation appliances may be more effective in reducing temporomandibular joint pain than soft stabilisation appliances.[55]Fricton J, Look JO, Wright E, et al. Systematic review and meta-analysis of randomized controlled trials evaluating intraoral orthopedic appliances for temporomandibular disorders. J Orofac Pain. 2010;24:237-54.
http://www.ncbi.nlm.nih.gov/pubmed/20664825?tool=bestpractice.com
Splints may help in relieving muscle spasm, offloading the joints, and changing the oral habits of patients that may contribute to TMDs.
Evidence for the efficacy of splints is mixed and of low certainty. One systematic review indicated that splints are useful in reducing pain, but not in improving masticatory function.[56]Ebrahim S, Montoya L, Busse JW, et al. The effectiveness of splint therapy in patients with temporomandibular disorders: a systematic review and meta-analysis. J Am Dent Assoc. 2012;143:847-57.
http://www.ncbi.nlm.nih.gov/pubmed/22855899?tool=bestpractice.com
Another systematic review concluded that occlusive splint therapy, alone or in combination with other treatment modalities, effectively reduced pain.[57]Tournavitis A, Sandris E, Theocharidou A, et al. Effectiveness of conservative therapeutic modalities for temporomandibular disorders-related pain: a systematic review. Acta Odontol Scand. 2023 May;81(4):286-97.
http://www.ncbi.nlm.nih.gov/pubmed/36354093?tool=bestpractice.com
However, one rapid review concluded that occlusal splint therapy was not recommended for the management of TMDs owing to lack of conclusive evidence.[58]Tran C, Ghahreman K, Huppa C, et al. Management of temporomandibular disorders: a rapid review of systematic reviews and guidelines. Int J Oral Maxillofac Surg. 2022 Sep;51(9):1211-25.
http://www.ncbi.nlm.nih.gov/pubmed/35339331?tool=bestpractice.com
Another systematic review found that evidence supporting the effectiveness of oral splints for the management of patients with TMDs and bruxism was of low certainty.[59]Riley P, Glenny AM, Worthington HV, et al. Oral splints for temporomandibular disorder or bruxism: a systematic review. Br Dent J. 2020 Feb;228(3):191-7.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718146
http://www.ncbi.nlm.nih.gov/pubmed/32060462?tool=bestpractice.com
Irreversible oral splints are not recommended.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227.
https://www.bmj.com/content/383/bmj-2023-076227.long
http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com
[51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226.
https://www.bmj.com/content/383/bmj-2023-076226.long
http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
In patients with chronic TMD pain (≥3 months), considerable reduction in pain can be achieved with CBT with or without biofeedback or relaxation therapy, therapist-assisted jaw mobilisation, and manual trigger point therapy.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227.
https://www.bmj.com/content/383/bmj-2023-076227.long
http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com
[51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226.
https://www.bmj.com/content/383/bmj-2023-076226.long
http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
Supervised postural and jaw exercises under the guidance of a consultant TMD physiotherapist, stretching with or without manual trigger point therapy, and patient education and self-management, although less effective than other treatments, can also aid in the management of chronic TMD pain.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227.
https://www.bmj.com/content/383/bmj-2023-076227.long
http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com
[51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226.
https://www.bmj.com/content/383/bmj-2023-076226.long
http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
Pharmacological therapy
Non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, low-dose antidepressants, or anticonvulsants can be used in patients with acute or persistent TMD pain in whom non-pharmacological interventions do not provide relief. Opioids are drugs of last choice and should be avoided unless under the guidance of a pain physician. The choice of treatment should be based on patients’ overall assessment and the presence of comorbidities.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78.
https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8
http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com
NSAIDs are most frequently used for acute TMD (after 2 weeks of joint rest and <3 months of duration).[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78.
https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8
http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com
[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7.
https://jcda.ca/h7
http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com
Oral NSAIDs may be helpful to relieve pain, and can relieve pain and inflammation in patients with osteoarthritis or internal derangement.[62]Kulkarni S, Thambar S, Arora H. Evaluating the effectiveness of nonsteroidal anti-inflammatory drug(s) for relief of pain associated with temporomandibular joint disorders: a systematic review. Clin Exp Dent Res. 2020 Feb;6(1):134-46.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025987
http://www.ncbi.nlm.nih.gov/pubmed/32067407?tool=bestpractice.com
[63]Montinaro F, Nucci L, d'Apuzzo F, et al. Oral nonsteroidal anti-inflammatory drugs as treatment of joint and muscle pain in temporomandibular disorders: a systematic review. Cranio. 2022 Feb 7:1-10.
http://www.ncbi.nlm.nih.gov/pubmed/35129419?tool=bestpractice.com
Topical NSAIDs (e.g., diclofenac) can be applied over the temporomandibular joint to alleviate joint pain. One systematic review reported reduction in pain and improved range of motion with NSAIDs, but a consensus could not be reached because of heterogeneity.[62]Kulkarni S, Thambar S, Arora H. Evaluating the effectiveness of nonsteroidal anti-inflammatory drug(s) for relief of pain associated with temporomandibular joint disorders: a systematic review. Clin Exp Dent Res. 2020 Feb;6(1):134-46.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025987
http://www.ncbi.nlm.nih.gov/pubmed/32067407?tool=bestpractice.com
Topical NSAIDs may be preferred because limited evidence suggests they are as effective as oral NSAIDs, but do not cause gastrointestinal side effects.[62]Kulkarni S, Thambar S, Arora H. Evaluating the effectiveness of nonsteroidal anti-inflammatory drug(s) for relief of pain associated with temporomandibular joint disorders: a systematic review. Clin Exp Dent Res. 2020 Feb;6(1):134-46.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025987
http://www.ncbi.nlm.nih.gov/pubmed/32067407?tool=bestpractice.com
Muscle relaxants act by reducing muscle hyperactivity and relieving muscle-related symptoms, and are typically used at initial presentation for up to 2 weeks.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78.
https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8
http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com
Benzodiazepines (e.g., diazepam), if used, must be limited to the initial treatment phase only (up to 2 weeks).[64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86.
https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html
http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com
Benzodiazepines are associated with misuse, abuse, and addiction, and should only be prescribed under the guidance of a pain management clinician. If TMD symptoms are muscle-related, cyclobenzaprine may be prescribed.[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7.
https://jcda.ca/h7
http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com
[64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86.
https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html
http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com
[65]Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Front. Oral Maxillofac. Med. 2022 Jun 10;4:17.
https://fomm.amegroups.org/article/view/52991/html#B10
Cyclobenzaprine is structurally related to benzodiazepines. It is contraindicated in patients with hyperthyroidism, congestive heart failure, arrhythmias, and recent heart attacks.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78.
https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8
http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com
Low-dose tricyclic antidepressants (e.g., amitriptyline) may aid in the management of chronic TMD pain (>3 months duration).[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7.
https://jcda.ca/h7
http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com
[64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86.
https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html
http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com
[66]Rizzatti-Barbosa CM, Nogueira MT, de Andrade ED, et al. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio. 2003 Jul;21(3):221-5.
http://www.ncbi.nlm.nih.gov/pubmed/12889679?tool=bestpractice.com
One randomised controlled trial found that low doses of amitriptyline reduced orofacial pain due to TMD.[67]de Sousa BM, López-Valverde A, Caramelo F, et al. Use of antidepressants in the treatment of chronic orofacial pain caused by temporomandibular disorders: a randomized controlled clinical trial. [in spa]. Med Clin (Barc). 2024 Jul 26;163(2):74-7.
http://www.ncbi.nlm.nih.gov/pubmed/38570297?tool=bestpractice.com
[68]ClinicalTrials.gov. Myofascial pain patients' response to the administration of low doses of amitriptyline and citalopram compared with the use of bite splint. ClinicalTrials.gov Identifier: NCT04777838. Mar 2021 [internet publication].
https://clinicaltrials.gov/study/NCT04777838
Adverse effects of tricyclic antidepressants include sedation, dizziness, blurred vision, constipation, cardiac complications, and xerostomia.[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7.
https://jcda.ca/h7
http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com
[65]Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Front. Oral Maxillofac. Med. 2022 Jun 10;4:17.
https://fomm.amegroups.org/article/view/52991/html#B10
Caution should be exercised when using these drugs in older patients and in those with cardiac conditions. Selective serotonin-reuptake inhibitors (SSRIs), one of the commonly used antidepressants, may cause jaw pain and/or bruxism, which can further exacerbate TMDs.[41]Wise M. Citalopram-induced bruxism. Br J Psychiatry. 2001 Feb;178:182.
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/citalopraminduced-bruxism/9FC0BF20588A99E5833F252043DEAD55
[42]Raja M, Raja S. Two cases of sleep bruxism associated with escitalopram treatment. J Clin Psychopharmacol. 2014 Jun;34(3):403-5.[43]Garrett AR, Hawley JS. SSRI-associated bruxism: a systematic review of published case reports. Neurol Clin Pract. 2018 Apr;8(2):135-41.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5914744
http://www.ncbi.nlm.nih.gov/pubmed/29708207?tool=bestpractice.com
Thus, they are not recommended for patients with TMDs.[69]Rajan R, Sun YM. Reevaluating antidepressant selection in patients with bruxism and temporomandibular joint disorder. J Psychiatr Pract. 2017 May;23(3):173-9.
http://www.ncbi.nlm.nih.gov/pubmed/28492455?tool=bestpractice.com
Anticonvulsants (e.g., gabapentin, pregabalin) may be prescribed to patients in whom temporomandibular joint surgery has failed or to those with persistent/chronic pain (>3 months duration).[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7.
https://jcda.ca/h7
http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com
[64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86.
https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html
http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com
[70]Kimos P, Biggs C, Mah J, et al. Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial. Pain. 2007 Jan;127(1-2):151-60.
http://www.ncbi.nlm.nih.gov/pubmed/17030096?tool=bestpractice.com
Opioid analgesics can effectively reduce pain and have been used in dentistry to manage moderate to severe pain. Opioids are generally not recommended in TMDs, and their use should be restricted for patients with chronic pain (>3 months duration) in whom non-opioid therapies are ineffective.[64]Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86.
https://www.aafp.org/pubs/afp/issues/2015/0315/p378.html
http://www.ncbi.nlm.nih.gov/pubmed/25822556?tool=bestpractice.com
Opioids (e.g., codeine, oxycodone) may be prescribed for short-term management of severe TMD pain.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78.
https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8
http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com
Hydromorphone may be used for severe intractable pain.[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7.
https://jcda.ca/h7
http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com
[65]Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Front. Oral Maxillofac. Med. 2022 Jun 10;4:17.
https://fomm.amegroups.org/article/view/52991/html#B10
Judicious use under physician supervision is warranted. Long-term use for chronic pain management is discouraged as it can result in addiction and/or overdose.[4]Busse JW, Casassus R, Carrasco-Labra A, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023 Dec 15;383:e076227.
https://www.bmj.com/content/383/bmj-2023-076227.long
http://www.ncbi.nlm.nih.gov/pubmed/38101929?tool=bestpractice.com
[51]Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023 Dec 15;383:e076226.
https://www.bmj.com/content/383/bmj-2023-076226.long
http://www.ncbi.nlm.nih.gov/pubmed/38101924?tool=bestpractice.com
[61]Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc. 2017 Jul;83:h7.
https://jcda.ca/h7
http://www.ncbi.nlm.nih.gov/pubmed/29513209?tool=bestpractice.com
[65]Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Front. Oral Maxillofac. Med. 2022 Jun 10;4:17.
https://fomm.amegroups.org/article/view/52991/html#B10
Fentanyl transdermal patches can be used as an alternative to the oral route.[60]Minervini G, Franco R, Crimi S, et al. Pharmacological therapy in the management of temporomandibular disorders and orofacial pain: a systematic review and meta-analysis. BMC Oral Health. 2024 Jan 13;24(1):78.
https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-023-03524-8
http://www.ncbi.nlm.nih.gov/pubmed/38218874?tool=bestpractice.com
Surgery
Referral to a maxillofacial surgeon should be considered urgently for patients with acute severe restriction of opening. Failure of improvement of symptoms of pain, restriction of opening, or locking after at least 6 weeks of management with splint, rest, and muscle massage warrants surgical intervention.
Surgery can be considered in patients with persistent significant joint pain, dysfunction that is disabling, and/or evidence of pathological conditions. Surgical procedures include arthrocentesis, arthroscopy, condylotomy, arthroplasty. disc surgery, and total TMJ replacement and normally follow a stepwise approach.[58]Tran C, Ghahreman K, Huppa C, et al. Management of temporomandibular disorders: a rapid review of systematic reviews and guidelines. Int J Oral Maxillofac Surg. 2022 Sep;51(9):1211-25.
http://www.ncbi.nlm.nih.gov/pubmed/35339331?tool=bestpractice.com
[71]Sidebottom AJ, Salha R. Management of the temporomandibular joint in rheumatoid disorders. Br J Oral Maxillofac Surg. 2013 Apr;51(3):191-8.
http://www.ncbi.nlm.nih.gov/pubmed/22658606?tool=bestpractice.com
[72]National Institute for Health and Care Excellence. Total prosthetic replacement of the temporomandibular joint. Aug 2014 [internet publication].
https://www.nice.org.uk/guidance/ipg500
[73]American Society of TMJ Surgeons. Surgical management of TMJ disorders [internet publication].
https://astmjs.org/surgical-management-of-tmj-disorders